Krsnaa Diagnostics (KRSNAA.NS) Earnings Analysis
Krsnaa Diagnostics (KRSNAA.NS) next reports earnings on 2026-08-06, consensus EPS 6.15 INR. Last quarter (2026-05-25) it beat with EPS 9.65 INR vs 2.45 INR est (+293.9%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E 17.12.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does KRSNAA.NS next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 6.15 INR |
| Revenue estimate | 2.21B |
KRSNAA.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-25 | 9.65 INR | 2.45 INR | +293.9% | Beat |
| 2026-02-05 | 4.9 INR | 6.07 INR | -19.3% | Miss |
| 2025-11-07 | 7.5 INR | 7.53 INR | -0.4% | Miss |
| 2025-08-11 | 6.4 INR | 8 INR | -20% | Miss |
| 2025-05-12 | 6.6 INR | 6.4 INR | +3.1% | Beat |
| 2024-10-25 | 5.92 INR | 8 INR | -26% | Miss |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
KRSNAA.NS valuation and analyst view
| Trailing P/E | 17.12 |
|---|---|
| Trailing EPS | 31.267 INR |
| Price / book | 1.77 |
| Dividend yield | 0.51% |
| Market cap | 17.57B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Krsnaa Diagnostics (KRSNAA.NS)'s next earnings date?
Krsnaa Diagnostics is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 6.15 INR and revenue estimate of 2.21B.
Did KRSNAA.NS beat earnings last quarter?
In its 2026-05-25 report, KRSNAA.NS posted EPS of 9.65 INR versus a 2.45 INR estimate — a beat of 293.9%.
What is KRSNAA.NS's earnings track record?
Over the last 6 reported quarters with consensus data, KRSNAA.NS beat estimates 2 times (33%).
What is KRSNAA.NS's current P/E ratio and EPS?
KRSNAA.NS trades at a trailing P/E of 17.12 on trailing EPS of 31.266646115906287 INR.
What do analysts rate KRSNAA.NS?
KRSNAA.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.